ArticleDermatology practical & conceptual2024

Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study.

Yu Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.